Compare PCRX & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | GOOS |
|---|---|---|
| Founded | 2006 | 1957 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 931.6M |
| IPO Year | 2010 | 2016 |
| Metric | PCRX | GOOS |
|---|---|---|
| Price | $36.35 | $8.09 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 12 |
| Target Price | ★ $33.57 | $9.49 |
| AVG Volume (30 Days) | ★ 2.1M | 634.9K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $3.84 | $3.26 |
| Revenue Next Year | $4.73 | $4.05 |
| P/E Ratio | $191.29 | ★ $75.22 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $7.36 |
| 52 Week High | $36.67 | $14.60 |
| Indicator | PCRX | GOOS |
|---|---|---|
| Relative Strength Index (RSI) | 83.97 | 55.14 |
| Support Level | $21.78 | $8.05 |
| Resistance Level | N/A | $8.32 |
| Average True Range (ATR) | 0.40 | 0.22 |
| MACD | 0.89 | 0.07 |
| Stochastic Oscillator | 97.44 | 63.93 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.